Health

#SFHS2608546ADecree of 26 March 2026 on the delisting of products under Title I of the list of reimbursable products and services provided for in Article L. 165-1 of the Social Security Code

🇫🇷France··Other·Medium Impact·View source ↗

AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.

🇬🇧 English

This French decree removes two specific reimbursement codes for Dexcom G6 continuous glucose monitoring (CGM) systems from the official list of products and services reimbursed by French social security. The codes 1155302 (initial forfait for interstitial glucose self-monitoring with Dexcom G6) and 1186202 (monthly forfait for the same system) are deleted from the section covering continuous interstitial glucose measurement devices under Chapter 1, Section 3. All references to these two codes are also removed wherever they appear in the entire Chapter 1 of the list. The delisting takes effect on the thirteenth day after publication in the Journal officiel. This action ends public reimbursement for the Dexcom G6 starter kit and monthly supplies in France.

AI-generated summary. May contain errors. Refer to official sources for legal decisions.

Key Changes

  • Deletion of reimbursement code 1155302: initial forfait for Dexcom G6 interstitial glucose self-monitoring
  • Deletion of reimbursement code 1186202: monthly forfait for Dexcom G6 interstitial glucose self-monitoring
  • Removal of all references to codes 1155302 and 1186202 throughout Chapter 1 of the reimbursable products list

+ 2 more changes with Pro

Obligations

What this law requires

high

Remove reimbursement code 1155302 (initial forfait for Dexcom G6 interstitial glucose self-monitoring) from Chapter 1, Section 3, Subsection 1 of Title I of the list of reimbursable products and services under Article L. 165-1 of the Social Security Code

French social security administration (Assurance Maladie)
operational
high

Remove reimbursement code 1186202 (monthly forfait for Dexcom G6 interstitial glucose self-monitoring) from Chapter 1, Section 3, Subsection 1 of Title I of the list of reimbursable products and services under Article L. 165-1 of the Social Security Code

French social security administration (Assurance Maladie)
operational
high

Delete all references to codes 1155302 and 1186202 wherever they appear throughout Chapter 1 of the reimbursable products and services list

French social security administration (Assurance Maladie)
operational
high

Implement the delisting effective on the thirteenth day following publication in the Journal officiel de la République française

French social security administration (Assurance Maladie)
operational
high

Publish this decree in the Journal officiel de la République française

French government authority responsible for official publications
disclosure

Affected Parties

Dexcom FrancePatients using Dexcom G6 CGM systems+2 more…

Tags

health reimbursement,medical devices,continuous glucose monitoring